Controlled trial demonstrates nano-iron sulfide improves growth, antioxidant capacity, and gut microbiota in broilers, indicating high bioavailability as an alternative iron supplement.
This study evaluated nano-iron sulfide (nFeS) as an iron source on the bioavailability, biocompatibility, and tolerance in broilers. Broilers were allocated to the five diets: an iron-deficient basal diet (ID), the basal diet with 80 mg Fe/kg as FeSO4, or 20, 40, or 80 mg Fe/kg as nFeS. Results showed that nFeS treatments (40, 80 mg/kg) improved average daily gain and feed conversion rate compared to ID, showed comparable or even superior effects to FeSO4 on growth performance during 1-21 days (p < 0.05). nFeS improved whole blood Hb content and PCV percentage at day 21, while increasing serum SOD and GSH-Px activities at day 42. nFeS (40, 80 mg/kg) had or tended to deposit higher iron content in liver, spleen, duodenum and serum than FeSO4 groups. nFeS significantly increased breast meat lightness and redness compared with the ID (p < 0.05) and showed comparable effects on postmortem pH, drip loss, and shear force relative to FeSO₄. nFeS reshaped the microbial composition in the jejunum and cecum, particularly enriching the abundance of beneficial bacteria such as Lactobacillus in the jejunum. At the dose up to 400 mg/kg, nFeS revealed no negative effects in broilers. In conclusion, nFeS is an effective iron supplement with high bioavailability and comparability, and additional benefit in shaping intestinal microbiota.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: